Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29888157 | 0.97 | ERBB2 (0.46) | ERBB2EGFR | |
| SCHEMBL29887758 | 0.96 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL24569620 | 0.96 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL24569813 | 0.96 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL29887989 | 0.96 | ERBB2 (0.52) | ERBB2EGFR | |
| SCHEMBL29888139 | 0.94 | ERBB2 (0.47) | ERBB2EGFR | |
| SCHEMBL24569471 | 0.90 | ERBB2 (0.50) | ERBB2EGFR | |
| SCHEMBL29888023 | 0.90 | ERBB2 (0.50) | ERBB2EGFR | |
| SCHEMBL24569327 | 0.90 | EGFR (0.45) | ERBB2EGFR | |
| SCHEMBL24569308 | 0.90 | ERBB2 (0.45) | ERBB2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267137-A1 | LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 | Enliven Inc. (US) | 2023-11-01 | — | — | EP | disclosed |
| WO-2022140769-A1 | LACTAM (HETERO)ARYLFUSEDPYRIMIDINE DERIVATIVES AS INHIBITORS OF ERBB2 | ENLIVEN THERAPEUTICS, INC. (US) | 2022-06-30 | — | — | WO | disclosed |